Loading...
CBAV logo

Clínica Baviera, S.A.BME:CBAV Stock Report

Market Cap €874.6m
Share Price
€54.60
€69
20.9% undervalued intrinsic discount
1Y41.1%
7D-1.4%
1D
Portfolio Value
​
View

Clínica Baviera, S.A.

BME:CBAV Stock Report

Market Cap: €874.6m

Clínica Baviera (CBAV) Stock Overview

A medical company, operates a network of ophthalmology clinics in Spain and Europe. More details

CBAV fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends4/6

Rewards

Trading at 32.9% below our estimate of its fair value

Earnings grew by 4.6% over the past year

Risk Analysis

Unstable dividend track record


CBAV Community Fair Values

Create Narrative

See what 24 others think this stock is worth. Follow their fair value or set your own to get alerts.

Top Community Narratives

CBAV logo
Clínica Baviera

The Undervaluation of Clinica Baviera: An Opportunity for Investors?

A steady eye-care business throws off a lot of cash, yet the market may be overlooking it. The big question is whether paying out so much to shareholders slows its growth less than people fear.
View narrative
€69
FV
20.9% undervalued intrinsic discount
13.20%
Revenue growth p.a.
62
users have viewed this narrative
2users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
View all narratives

Clínica Baviera, S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Clínica Baviera
Historical stock prices
Current Share Price€54.60
52 Week High€58.00
52 Week Low€37.80
Beta0.77
1 Month Change3.02%
3 Month Change4.20%
1 Year Change41.09%
3 Year Change188.89%
5 Year Change273.97%
Change since IPO140.95%

Recent News & Updates

Analysis Article • Jan 24

We Think Clínica Baviera (BME:CBAV) Can Manage Its Debt With Ease

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Recent updates

Analysis Article • Jan 24

We Think Clínica Baviera (BME:CBAV) Can Manage Its Debt With Ease

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Apr 10

A Piece Of The Puzzle Missing From Clínica Baviera, S.A.'s (BME:CBAV) Share Price

With a price-to-earnings (or "P/E") ratio of 13x Clínica Baviera, S.A. ( BME:CBAV ) may be sending bullish signals at...
Analysis Article • Oct 18

Clínica Baviera (BME:CBAV) Is Achieving High Returns On Its Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
Analysis Article • Sep 19

Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Jul 13

Market Cool On Clínica Baviera, S.A.'s (BME:CBAV) Earnings

Clínica Baviera, S.A.'s ( BME:CBAV ) price-to-earnings (or "P/E") ratio of 14.5x might make it look like a buy right...
Analysis Article • Mar 01

Clínica Baviera (BME:CBAV) Might Become A Compounding Machine

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Analysis Article • Nov 20

Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405

The board of Clínica Baviera, S.A. ( BME:CBAV ) has announced that it will pay a dividend of €0.405 per share on the...
Analysis Article • Jan 20

Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
Analysis Article • Sep 15

These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analysis Article • Apr 12

Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analysis Article • Mar 21

Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Feb 22

Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?

Most readers would already be aware that Clínica Baviera's (BME:CBAV) stock increased significantly by 28% over the...
Analysis Article • Jan 30

Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return

It might be of some concern to shareholders to see the Clínica Baviera, S.A. ( BME:CBAV ) share price down 16% in the...
Analysis Article • Jan 09

Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analysis Article • Dec 19

Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative

It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. Having...
Analysis Article • Nov 28

Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Shareholder Returns

CBAVES HealthcareES Market
7D-1.4%2.1%1.0%
1Y41.1%-7.6%22.7%

Return vs Industry: CBAV exceeded the Spanish Healthcare industry which returned -8.3% over the past year.

Return vs Market: CBAV exceeded the Spanish Market which returned 22.7% over the past year.

Price Volatility

Is CBAV's price volatile compared to industry and market?
CBAV volatility
CBAV Average Weekly Movement3.6%
Healthcare Industry Average Movement5.1%
Market Average Movement3.9%
10% most volatile stocks in ES Market6.7%
10% least volatile stocks in ES Market0.9%

Stable Share Price: CBAV has not had significant price volatility in the past 3 months compared to the Spanish market.

Volatility Over Time: CBAV's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19921,592Eduardo Baviera Sabaterwww.clinicabaviera.com

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, and intraocular lenses treatments.

Clínica Baviera, S.A. Fundamentals Summary

How do Clínica Baviera's earnings and revenue compare to its market cap?
CBAV fundamental statistics
Market cap€874.61m
Earnings (TTM)€42.06m
Revenue (TTM)€304.91m
20.8x
P/E Ratio
2.9x
P/S Ratio

Is CBAV overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CBAV income statement (TTM)
Revenue€304.91m
Cost of Revenue€153.93m
Gross Profit€150.98m
Other Expenses€108.92m
Earnings€42.06m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)2.63
Gross Margin49.52%
Net Profit Margin13.80%
Debt/Equity Ratio7.1%

How did CBAV perform over the long term?

See historical performance and comparison

Dividends

2.9%
Current Dividend Yield
60%
Payout Ratio

Does CBAV pay a reliable dividends?

See CBAV dividend history and benchmarks
When do you need to buy CBAV by to receive an upcoming dividend?
Clínica Baviera dividend dates
Ex Dividend DateJun 10 2026
Dividend Pay DateJun 12 2026
Days until Ex dividend19 days
Days until Dividend pay date21 days

Does CBAV pay a reliable dividends?

See CBAV dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/21 06:10
End of Day Share Price 2026/05/21 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Clínica Baviera, S.A. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
León Izuzquiza LenzeBanco de Sabadell. S.A.
Marta DiazBanco de Sabadell. S.A.
Bosco Muguiro EulateBanco Santander